ZA937474B - Quinolonecarboxylic acids - Google Patents

Quinolonecarboxylic acids

Info

Publication number
ZA937474B
ZA937474B ZA937474A ZA937474A ZA937474B ZA 937474 B ZA937474 B ZA 937474B ZA 937474 A ZA937474 A ZA 937474A ZA 937474 A ZA937474 A ZA 937474A ZA 937474 B ZA937474 B ZA 937474B
Authority
ZA
South Africa
Prior art keywords
quinolonecarboxylic acids
quinolonecarboxylic
acids
Prior art date
Application number
ZA937474A
Other languages
English (en)
Inventor
Uwe Petersen
Wilfried Schroeck
Dieter Haebich
Andreas Krebs
Thomas Schenke
Thomas Philipps
Klaus Grohe
Rainer Endermann
Klaus-Dieter Bremm
Karl-Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA937474B publication Critical patent/ZA937474B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA937474A 1992-10-09 1993-10-08 Quinolonecarboxylic acids ZA937474B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4234078A DE4234078A1 (de) 1992-10-09 1992-10-09 Chinoloncarbonsäuren

Publications (1)

Publication Number Publication Date
ZA937474B true ZA937474B (en) 1994-04-26

Family

ID=6470084

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937474A ZA937474B (en) 1992-10-09 1993-10-08 Quinolonecarboxylic acids

Country Status (19)

Country Link
US (1) US5480879A (OSRAM)
EP (1) EP0591808A1 (OSRAM)
JP (1) JPH0820587A (OSRAM)
KR (1) KR940009193A (OSRAM)
CN (1) CN1090285A (OSRAM)
AU (1) AU666772B2 (OSRAM)
CA (1) CA2107812A1 (OSRAM)
CZ (1) CZ9302001A3 (OSRAM)
DE (1) DE4234078A1 (OSRAM)
FI (1) FI934411L (OSRAM)
HU (1) HUT66376A (OSRAM)
IL (1) IL107188A0 (OSRAM)
MX (1) MX9306023A (OSRAM)
NO (1) NO933393L (OSRAM)
NZ (1) NZ248871A (OSRAM)
PL (1) PL300628A1 (OSRAM)
SK (1) SK109293A3 (OSRAM)
TW (1) TW288018B (OSRAM)
ZA (1) ZA937474B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0746561B1 (en) * 1994-02-25 1999-04-28 Laboratorios Aranda, S.A. De C.V. (Mx/Mx) Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
WO1996025417A1 (en) * 1995-02-17 1996-08-22 Suntory Limited Penem derivatives and antimicrobial agent containing the same
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
AR013493A1 (es) 1997-09-15 2000-12-27 Procter & Gamble COMPUESTO DE QUINOLONA, SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO Y COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE19927412A1 (de) * 1999-06-16 2000-12-21 Bayer Ag Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0]nonan
DE19931115A1 (de) * 1999-07-06 2001-01-11 Bayer Ag Racemisierung von R, S-Dioxo-Benzylpyrrolopiperidin
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
KR20120099725A (ko) * 2004-06-10 2012-09-11 포브 신서시스 인코포레이티드 그램-음성 활성을 갖는 카바페넴 항균제 및 그의 제조방법
CN1325494C (zh) * 2005-08-18 2007-07-11 中国药科大学 3－位取代的萘啶酮类化合物及其制备方法和在制药中的应用
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
KR101102288B1 (ko) 2006-03-28 2012-01-03 워너 칠콧 컴퍼니 엘엘씨 (3ｓ,5ｓ)-7-(3-아미노-5-메틸-피페리디닐)-1-사이클로프로필-1,4-다이하이드로-8-메톡시-4-옥소-3-퀴놀린카르복실산의 말레이트 염 및 다형체
US7692015B2 (en) * 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
FR2928150A1 (fr) 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
IT1393337B1 (it) 2009-03-06 2012-04-20 Italiana Sint Spa Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
EP2590978B1 (en) 2010-06-18 2017-09-20 FOB Synthesis, Inc. Carbapenem antibacterials with gram-negative activity
CN102952130B (zh) * 2011-08-24 2016-03-23 重庆华邦胜凯制药有限公司 手性合成(s,s)-2,8-二氮杂双环壬烷的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU63689A (en) * 1988-03-31 1991-06-30 Hoffmann La Roche Acyl derivatives
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
JPH03188080A (ja) * 1989-12-15 1991-08-16 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
EP0492277A3 (en) * 1990-12-20 1992-10-14 F. Hoffmann-La Roche Ag Cephalosporin derivatives

Also Published As

Publication number Publication date
FI934411A7 (fi) 1994-04-10
KR940009193A (ko) 1994-05-20
MX9306023A (es) 1994-05-31
JPH0820587A (ja) 1996-01-23
PL300628A1 (en) 1994-05-16
NO933393L (no) 1994-04-11
HU9302843D0 (en) 1993-12-28
SK109293A3 (en) 1994-09-07
DE4234078A1 (de) 1994-04-14
NZ248871A (en) 1995-12-21
IL107188A0 (en) 1994-01-25
FI934411L (fi) 1994-04-10
NO933393D0 (no) 1993-09-23
HUT66376A (en) 1994-11-28
EP0591808A1 (de) 1994-04-13
CA2107812A1 (en) 1994-04-10
CN1090285A (zh) 1994-08-03
AU4864493A (en) 1994-04-21
FI934411A0 (fi) 1993-10-07
CZ9302001A3 (en) 1994-04-13
US5480879A (en) 1996-01-02
TW288018B (OSRAM) 1996-10-11
AU666772B2 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
AP9200416A0 (en) Imidazolyl-alkenoic acids
DE69307690D1 (en) Implantierbare penis-prothese
ZA937474B (en) Quinolonecarboxylic acids
AU115931S (en) Cuff-link
DE59302394D1 (en) Linearlagerelement
DE69306746D1 (en) Schlichtmittelzusammensetzung
ZA933879B (en) ZSM-5-zeolite
GB9325558D0 (en) Percaboxylic acids
AU116869S (en) Bottle-cooler
DE69310500D1 (en) Racemisierungsverfahren
ZA938988B (en) Substituted benzoic acids
AU116434S (en) Sponge-squeegee
ZA956017B (en) Heterocyclyl-1-phenyl-substituted quinolonecarboxylic acids
ZA955966B (en) New N1-miscellaneous 6-fluoro-8-difluoromethoxy-substituted quinolonecarboxylic acids
ZA933757B (en) Cyclopentane-and-pentene-beta-amino acids
ZA936367B (en) Esters
GB9200734D0 (en) Phenylpyrazine ethines
GB9308107D0 (en) Polecat
AU940P (en) KISMET Chamelaucium uncinatum
AU499P (en) BAYAMO Desmanthus virgatus
CA70408S (en) Hairsetter
CA71063S (en) Montre-chronographe
GB9221636D0 (en) Esters
GB9221512D0 (en) Phenylpyrazine esters
GB9225072D0 (en) Controller